What was a key takeaway from the BOLDER study?

The key takeaway from the BOLDER study is that ultra-low BurstDR settings provide maximum therapeutic longevity while still maintaining effective pain relief. This finding is significant as it suggests that patients can achieve satisfactory pain management over extended periods without the need for higher power settings, which may not only be less sustainable but could also potentially lead to quicker battery depletion in devices used for pain management.

The study highlights the balancing act between achieving effective pain relief and ensuring the longevity of the therapeutic device's battery life. With ultra-low settings, patients can benefit from long-lasting pain relief that does not compromise the functionality and duration of their pain management solution. This aspect is particularly important for individuals relying on devices such as spinal cord stimulators, as it can lead to improved quality of life and reduced need for device replacements.